Pluristem Therapeutics to Expand Testing of PLX Cells for the Treatment of Radiation Exposure
HAIFA, Israel, April 6, 2011 (GLOBE NEWSWIRE) — Pluristem Therapeutics, Inc. (Nasdaq:PSTI – News) (TASE:PLTR – News) announced today that it has signed a collaborative agreement with the Hadassah University Medical Center to continue previously conducted animal study that indicates PLX cells are potentially effective in the treatment of radiation sickness.
Pluristem Therapeutics to Expand Testing of PLX Cells for the Treatment of Radiation Exposure
HAIFA, Israel, April 6, 2011 (GLOBE NEWSWIRE) — Pluristem Therapeutics, Inc. (Nasdaq:PSTI – News) (TASE:PLTR – News) announced today that it has signed a collaborative agreement with the Hadassah University Medical Center to continue previously conducted animal study that indicates PLX cells are potentially effective in the treatment of radiation sickness.
CorporateProfile 10 months ago